In vitro Inhibition of Canine Complement‐Mediated Hemolysis

BACKGROUND: Immune‐mediated hemolytic anemia (IMHA) is the most common hematologic immune‐mediated disease in dogs. Complement fixation on erythrocytes causes hemolysis. Complement inhibition decreases hemolysis in people with the hemolytic disease and also may prove effective in treating IMHA in do...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernandez, D.M., Goggs, R., Behling‐Kelly, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
SMALL ANIMAL
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787187/
https://www.ncbi.nlm.nih.gov/pubmed/29171101
http://dx.doi.org/10.1111/jvim.14871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787187/
https://www.ncbi.nlm.nih.gov/pubmed/29171101
http://dx.doi.org/10.1111/jvim.14871

Ejemplares similares